Dr Riccardo Natoli's primary research interest is in the study of factors causing blindness, predominantly photoreceptor degeneration, and in devising therapies for protecting against vision loss. He is an Early Career Research teaching Genetics at the ANU Medical School and conducting research at the John Curtin School of Medical Research (JCSMR).
Dr Natoli's vision for entrepreneurial research engagement is to establish internationally recognised translational research capability to identify novel treatments and diagnostics, and to assist partners in validating novel treatments for retinal degenerations.
This Fellowship will be built on four synergistic pillars of translational engagement to provide sustainable research capabilities, delivering improved healthcare outcomes for Age-Related Macular Degeneration (AMD). These pillars are developing and optimise client IP, sponsoring research, generating new ANU IP and philanthropic entrepreneurial research.